Latest Production News

Lunnon Metals has secured critical mining proposal approval for its Lady Herial gold deposit, moving the project closer to production under a binding ore purchase deal with St Ives Gold Mining.

Encounter Resources reports significant extensions of shallow, high-grade niobium mineralisation east of its Green Mineral Resource Estimate at the Aileron Project, with promising drill results and a major development program planned for 2026.

Harmoney Corp Limited reported a staggering 742% increase in Cash NPAT for FY25, driven by its new Stellare® 2.0 platform and operational efficiencies. The company reaffirmed its ambitious $12 million profit target for FY26 while unveiling a secured car loan product and securing a major bank debt facility.

Resources & Energy Group Limited has raised $2 million to fund drilling and production expansion at its East Menzies Gold Project, following a year of significant operational milestones.

Orezone Gold Corporation has successfully completed commissioning of its Bomboré hard rock expansion, achieving first gold production and setting the stage for a significant increase in output next year.

EV Resources reports exceptional antimony recovery at its Los Lirios project using a simplified gravity process, paving the way for a lower-cost, accelerated development timeline.

International Graphite Limited has signed a non-binding letter of intent with Alkeemia S.p.A to access graphite purification tolling services at a new Italian plant starting early 2026, aiming to boost its high-purity graphite supply while minimizing capital costs.

Gibb River Diamonds has begun trucking and processing operations at its Neta Gold Mine, securing 130,000 tonnes of ore for milling at two contracted facilities in Western Australia.

CONNEQT Health’s Pulse arterial health monitor sales have outpaced expectations with over 200% growth in the December quarter, driven by efficient marketing and early subscription uptake.

Aureka Limited has raised $3.6 million through a share placement to fund a second diamond drill rig and accelerate exploration at its Victorian gold projects, reflecting strong investor confidence following recent high-grade discoveries.

Recce Pharmaceuticals has won a significant Australian Government R&D tax incentive, unlocking up to A$85 million for its synthetic anti-infective programs worldwide, including a pivotal Phase 3 clinical trial.

HITIQ Limited has successfully completed the initial tranche of a $900,000 placement, issuing over 40 million shares with attached options, while director participation awaits shareholder approval.